REFERENCES
- Abdeen Z., Bruce J. M., Guyan P. M., Land E. J., Mukerjee T., Swallow J. J. Chem. Research (S) 1985; 25: 4–255
- Arcamone F. Antibiot. Chem 1978; 2: 99–239, [CSA]
- Beedassy A., Cardi G. Semin. Oncol 1990; 26: 428–438, [CSA]
- Beijnen J. H., Wiese G., Underberg W. J. Pharm. Weekbl. Sci 1985; 7: 109–16, [PUBMED], [INFOTRIEVE], [CSA]
- Beijnen J. H., Potman R. P., van Ooijen R. D., Driebergen R. J., Voskuilen M. C. H., Renema J., Undergerg W. J. M. Int. J. Pharm 1987; 34: 247–257, [CSA], [CROSSREF]
- Beijnen J. H., van der Houwen O. A. G. J., Underberg W. J. M. Int. J. Pharm 1986; 32: 123–131, [CSA], [CROSSREF]
- D'Souza A. J., Topp E. M. J. Pharm. Sci 2004; 93: 1962–1979, [CSA], [CROSSREF]
- DeFeo-Jones D., Garsky V. M., Wong B. K., Feng D-M, Bolyar T, Haskell K., Kiefer D. M., Leander K., McAvoy E., Lumma P., Wai J., Senderak E. T., Motzel S. L., Keenan K., Van Zwieten M., Lin J. H., Freidinger R., Huff J., Oliff A., Jones R. E. Nature Medicine 2000; 6: 1248–1252, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- DiPaola R. S., Rinehart J., Nemunaitis J., Ebbinghaus S., Rubin E., Capanna T., Ciardella M., Doyle-Lindrud S., Goodwin S., Fontaine M., Adams N., Williams A., Schwartz M., Winchell G., Wickersham K., Deutsch P., Yao S. L. J. Clin. Oncol 2002; 20: 1874–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Eigen M. Angew. Chem. Int. Ed. Engl 1964; 3: 1, [CSA], [CROSSREF]
- Feng K.-I, Schelly Z. A. J. Phys. Chem 1995; 99: 17207–17211, [CSA], [CROSSREF]
- Garsky V. M., Lumma P. K., Feng D-M., Wai J., Ramjit H. G., Sardana M. K., Oliff A., Jones R. E., Defeo-Jones D., Freidinger R. M. J. Med. Chem 2001; 44: 4216–4224, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hubert A., Lyass O., Pode D., Gabizon A. Anticancer Drugs 2000; 11: 123–7, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Husain M. H., Blumenstein B., Eisenberger M., Crawford E. D. Semin. Oncol 1996; 2(6 suppl. 14)24–27, [CSA]
- Karki S. B., Ostovic D. Int. J. Pharm 2004; 271: 181–7, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Karki S. B., Cameron M., Lieberman D. R., Lynch J. E., Robbins M. A., Shi Y.-J., Almarsson Ö, Kaufman M.J., Nerurkar M.J. Salt form of a conjugate useful in the treatment of prostate cancer. Patent number WO00130804, (2001-05-03)
- Phillies G. D. J. Analytical Chemistry 1990; 62: 1049A–1057A, [CSA]
- Wassermann K., Bundgaard H. Int. J. Pharm 1983; 14: 73–78, [CSA], [CROSSREF]